| Analysis | Metabolite Name | Measured Value | Units | Gender:male | Glycemic status:Pre-diabetic | Neuropathy |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 1148267 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 1909342 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 2943879 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 2954903 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3083943 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3254171 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3296671 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3478870 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3520209 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3597878 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3599440 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3676514 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 3837415 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4052984 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4169063 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4203213 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4419248 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4482253 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4537997 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4551825 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4737157 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4789217 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 4962022 | Peak area normalized | Neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 5027039 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 5209803 | Peak area normalized | no neuropathy |
| Reversed phase NEGATIVE ION MODE | URIDINE (M+CL)- | 6556420 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 9134 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 9681 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 13398 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 14909 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 15057 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 15964 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 16835 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 16996 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 17181 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 18498 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 19223 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 19705 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 19779 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 20496 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 20692 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 21061 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 22435 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 22497 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 22594 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 23082 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 24748 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 26330 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 28185 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 29062 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 30606 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+H)+ | 30842 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 30541 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 37706 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 39384 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 39468 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 40286 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 41058 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 41810 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 45782 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 47329 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 47449 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 48544 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 49033 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 50316 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 51248 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 52176 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 53304 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 55712 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 56095 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 56719 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 57202 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 59046 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 59416 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 66502 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 74921 | Peak area normalized | no neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 81297 | Peak area normalized | Neuropathy |
| Reversed phase POSITIVE ION MODE | URIDINE (M+NA)+ | 103096 | Peak area normalized | no neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|